SCbio’s Post

I am pleased to share this impactful #ClinicalStudy that delves into the comparative diagnostic performance of four major #HCC guidelines, enhanced by cutting-edge MRI techniques and a novel automatic algorithm. Conducted across 11 South Korean hospitals, this retrospective study encompasses 2,237 high-risk patients and evaluates 2,445 focal liver lesions with a focus on accuracy, sensitivity, and specificity. It also shows one of the many ways in which #mintLesion™ might benefit your work! Read more on the topic here: https://bit.ly/4eFNfp5 Get updates on expert insights and the latest studies using #mintLesion™ to transform medical research by following #ResearchWithMint.

I am pleased to share this impactful #ClinicalStudy that delves into the comparative diagnostic performance of four major #HCC guidelines, enhanced by cutting-edge MRI techniques and a novel automatic algorithm. Conducted across 11 South Korean hospitals, this retrospective study encompasses 2,237 high-risk patients and evaluates 2,445 focal liver lesions with a focus on accuracy, sensitivity, and specificity. It also shows one of the many ways in which #mintLesion™ might benefit your work! Read more on the topic here: https://bit.ly/4eFNfp5 Get updates on expert insights and the latest studies using #mintLesion™ to transform medical research by following #ResearchWithMint.

I am pleased to share this impactful #ClinicalStudy that delves into the comparative diagnostic performance of four major #HCC guidelines, enhanced by cutting-edge MRI techniques and a novel automatic algorithm. Conducted across 11 South Korean hospitals, this retrospective study encompasses 2,237 high-risk patients and evaluates 2,445 focal liver lesions with a focus on accuracy, sensitivity, and specificity. It also shows one of the many ways in which #mintLesion™ might benefit your work! Read more on the topic here: https://bit.ly/4eFNfp5 Get updates on expert insights and the latest studies using #mintLesion™ to transform medical research by following #ResearchWithMint.

I am pleased to share this impactful #ClinicalStudy that delves into the comparative diagnostic performance of four major #HCC guidelines, enhanced by cutting-edge MRI techniques and a novel automatic algorithm. Conducted across 11 South Korean hospitals, this retrospective study encompasses 2,237 high-risk patients and evaluates 2,445 focal liver lesions with a focus on accuracy, sensitivity, and specificity. It also shows one of the many ways in which #mintLesion™ might benefit your work! Read more on the topic here: https://bit.ly/4eFNfp5 Get updates on expert insights and the latest studies using #mintLesion™ to transform medical research by following #ResearchWithMint.

Today in the #Chicagoland area, we are expected to get 10-12" of snow. For Abbott | Neuromodulation patients, the option to receive care from the comfort & safety of their home with #VirtualProgramming and #Neurosphere is still a reality. ----------------- #Abbott #RemoteProgramming #AbbottProud

📢We've Moved! New Website & Social Page Updates 🌐 Neurosign website has moved to 👉 www.technomedmedical.com! We'll also be sharing Neurosign news and updates on our Technomed, Medical Accessories page moving forward. Visit our improved website for comprehensive information about Neurosign products. Stay connected with us in this new chapter! #NewWebsiteLaunch #TechUpdate #Neurosign #Technomedmedical #ClinicalNeurophysiology #IONM #StayConnected #WebsiteLaunch

CEO and Co-Founder Revive Medical Technologies Inc. Prof. Dr. Murtaza Najabat Ali (CEng (UK) FIMechE PE) met Mr. Mike Ryan Co-founder of NeuroSonic in USA, where they discussed about potential to collaborate where Revive Medical Technologies Inc. can provide R&D and regulatory services for the telestroke devices and related technologies for early detection of stroke. NeuroSonic aims to revolutionize stroke healthcare by developing a remote stroke risk monitoring device that uses machine learning to monitor stroke risk and overall cardiovascular health. Their goal is to empower convenient at-home monitoring, providing timely information and intervention to promote longevity. This potential collaboration highlights a major advancement in using cutting-edge technology to improve stroke care. With NeuroSonic's state-of-the-art inventions and Revive Medical Technologies Inc.'s research and development expertise, the partnership hopes to produce groundbreaking instruments that can enhance early diagnosis and treatment outcomes for stroke patients. #ReviveMedicalTechnologies #neurosonic #StrokeCare #telestrok #HealthcareInnovation #medicaltechnology #strokeprevention #earlydiagnosissaveslives #machinelearning #cardiovascularhealth #HealthcareCollaboration #remotemonitoring #patientcare

Tivic Health's commitment to innovation in bioelectronic medicine takes another step forward with our recent completion of enrollment for a study focused on a novel, non-invasive approach to vagus nerve stimulation (VNS). This development represents our ongoing efforts to refine and expand the applications of our bioelectronic technology beyond our existing product offerings. By aiming for more precise vagus nerve signal manipulation, we're not just advancing our product portfolio but also contributing to the broader neurostimulation field. Our collaboration with The Feinstein Institutes for Medical Research underscores the rigorous, science-driven approach we're taking to unlock new therapeutic potentials. As we await the study's results, we remain dedicated to exploring how bioelectronic medicine can provide safer, drug-free options for those in need. www.tivichealth.com #tivic #nasdaq #tivc #clearup #bioelectronic #sinus Jennifer Ernst Tivic Health Blake Gurfein, PhD

✨ 𝐅𝐃𝐀 𝐆𝐫𝐞𝐞𝐧𝐥𝐢𝐠𝐡𝐭𝐬 𝐆𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞: 𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐧𝐠 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐌𝐑𝐈 𝐒𝐜𝐚𝐧𝐬 🔍 𝗜𝗻 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟰, The FDA has granted a #denovo clearance to an #artificialintelligence program capable of reading a standard brain #MRIscan and predicting a patient’s chances of progressing from mild cognitive impairment and early memory loss to #Alzheimer’s disease and dementia within five years. The #BrainSee prognostic program, which has been likened to a #virtualmicroscope, may be used in place of or in addition to cerebrospinal fluid #biopsies, or prior to positron emission tomography (#PET) scans, which necessitate the injection of radioactive tracers. BrainSee provides a numerical score ranging from 0 to 100, which enables patients to be grouped according to their risk while evaluating possible treatment alternatives. The FDA has previously designated BrainSee as a breakthrough #technology. ⏩𝑶𝒕𝒉𝒆𝒓 𝑹𝒆𝒍𝒂𝒕𝒆𝒅 𝑹𝒆𝒑𝒐𝒓𝒕:https://bit.ly/3O5J36c #aihealthcare #AlzheimersPrediction #fdaapproval #MRIInsights #neurotech #medicalinnovation #prophecymarketinsights

🫀#AERJournal (Impact Factor: 2.6) is calling for submissions! AER accepts reviews, original research papers, systematic review articles, case reports and expert opinions on clinical arrhythmias, ablation techniques, basic electrophysiology, and many more topics 👉 https://ow.ly/QHuf50ST5KE Featured Articles on: ✅Endocardial Pulsed Field Ablation and the Oesophagus 👉 https://ow.ly/2u6I50ST5KG ✅Atrial High-rate Episodes in Pts with No Prior #AFib 👉 https://ow.ly/Kpvk50ST5KH ✅ Personalised Cardiac Computational Modelling 👉 https://ow.ly/QOtw50ST5KF #EPeeps #CardioEd